Quantcast

Latest Art games Stories

2014-09-04 16:24:29

Based on Acclaimed PlayStation® Game CULVER CITY, Calif., Sept. 4, 2014 /PRNewswire/ -- Sony Pictures Entertainment today announced that Andres Muschietti has signed on to direct the highly-anticipated adaptation of best-selling PlayStation(®) software title, "Shadow of the Colossus." Seth Lochhead to write the screenplay (under Muschietti's supervision). Barbara Muschietti will come on board the project to produce alongside Kevin Misher, who produces through his Misher Films...

2014-08-29 08:24:15

VANCOUVER, Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the six months ended June 30, 2014. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS"). Second Quarter 2014 Highlights -- Announced top-line results related to the eight month visual acuity (VA) primary endpoint for subjects enrolled in the...

2014-08-19 08:29:32

VANCOUVER, Aug. 19, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF), today reported results of its Oral Amphotericin B (Oral Amp B) drug candidate targeting latent HIV reservoirs. The study, conducted by ImmuneCarta®, the immune monitoring business unit of Caprion, evaluated in vitro effectiveness of Oral Amp B in reactivating latent HIV viral reservoirs which remain present in individuals despite intensive treatment with...

2014-06-30 08:29:48

VANCOUVER, June 30, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF) today announced that all nominees listed in the management information circular dated May 28, 2014 were elected as directors at its 2014 Annual Meeting of Shareholders, held on Friday, June 27, 2014. On a vote by ballot, the following five nominees proposed by management were elected as Directors of iCo Therapeutics to serve until the Company's next Annual Meeting of...

2014-05-29 16:27:05

VANCOUVER, May 29, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the quarter ended March 31, 2014. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS"). "Excellent progress was made in the first quarter with the final eight month patient visit in our iDEAL study," said Andrew Rae, President & CEO of iCo...

2014-02-25 12:28:26

VANCOUVER, Feb. 25, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF) today announced that its United States trading symbol ICOTF has received approval from The Depository Trust Company (the "DTC"), thus providing the Company with DTC eligibility. DTC eligibility allows for iCo Therapeutics shares to be easily and economically transferred between brokerage accounts electronically. The DTC is the largest securities depository in the...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related